To better understand the relationship between vaccination and PASC risk in this patient population, researchers utilized the TriNetX health research database. Data from more than 3 million adults who tested...
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
Researchers compared pre-exposure prophylaxis (PrEP) use with birth outcomes using objective levels of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) of women during the second or third trimester...
Researchers conducted an observational study that examined the likelihood of newborns and infants having measles antibodies passed down from their mothers.
The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.
This COVID-19 roundup includes coverage on a revised version of the FDA’s emergency use authorization of tixagevimab/cilgavimab, a new study that compared the efficacy of vaccines and boosters in mortality...
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
This COVID-19 roundup includes coverage on vaccine safety for older adults, the efficacy of fluvoxamine on COVID-19 symptoms, the use of convalescent plasma transfusion in immunocompromised patients, and...
Researchers examined the efficacy of post-exposure prophylaxis for the prevention of sexually transmitted infections among certain patient populations living with HIV or on HIV pre-exposure prophylaxis.
...
Researchers examined the effectiveness of the monoclonal antibody, nirsevimab, in protecting infants from the respiratory syncytial virus (RSV) and RSV lower respiratory tract infection.
